Wuxi Pharmaceutical (WX), a biotechnology and pharmaceutical research company, doubled its quarterly profits.
China is moving up the value chain. In the old days,
American companies outsourced their manufacturing needs to China. Today, American companies are outsourcing more valuable services, such as
biotechnology R&D, to Chinese companies.
Wuxi can not only produce the same research and clinical trials cheaper than its American counterparts, it can do it
faster.
Related posts:
- IBM opens research center in Shanghai IBM opened its first research center in Beijing in 1995 but it understands the long-term global importance ofChina to its...
- Caterpillar enjoys booming Chinese business How is the heavy equipment business doing in China? Here is what Caterpillar said. Caterpillar said it expects its sales...
- Post Olympic tourism to boom in China. According to a new Nielsen survey, a whopping 80% of peoplesurveyed would like to visit China after watching theBeijing Olympics....



{ 0 comments… add one now }